Home/Arcus Biosciences/Kathryn Falberg
KF

Kathryn Falberg

Board of Directors Member

Arcus Biosciences

Therapeutic Areas

Arcus Biosciences Pipeline

DrugIndicationPhase
CasdatifanLate-line Kidney CancerPhase 3
Inflammation ProgramsNot SpecifiedNot Specified